The "King Kong" of weight loss medications, Mounjaro (tirzepatide), is a dual GIP and GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus and for weight loss. As with any medication affecting pancreatic function, questions have emerged regarding potential links between Mounjaro and pancreatic cancer. Current evidence from clinical trials and regulatory reviews does not establish a causal relationship between tirzepatide and pancreatic malignancy. L

Labour MP for Neath and Swansea East Carolyn Harris has said using Mounjaro has changed her lifestyle completely. As a woman who is going through the menopause she has seen first hand the impact hormonal health has on weight gain and loss. Labour MP for Neath and Swansea East Carolyn Harris Having had a positive experience on the weight-loss drug, Carolyn is campaigning for the Government to widen the current criteria that is needed to have Mounjaro prescribed on the NHS. Alt

Mounjaro works by activating areas in the brain that sense fullness and regulate food intake. This helps reduce appetite while enhancing satiety, meaning you feel content with less food. Over time, it can help reshape eating patterns by supporting a more natural balance between hunger and satisfaction. The science behind hunger control Appetite control depends on communication between the gut and the brain. After eating, the body releases two hormones — GLP-1 (glucagon-like p

Mounjaro mimics the effects of GIP and GLP-1 hormones, which influence brain regions that control hunger and satiety. It slows stomach emptying, helping you feel full for longer after eating smaller portions. By reducing cravings and promoting fullness, it makes it easier to stick to balanced, mindful eating habits. How the GIP and GLP-1 hormones signal fullness Both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) are gut hormones releas

Mounjaro is most effective when combined with a balanced diet and regular movement, such as walking, swimming, or cycling. The medication helps regulate appetite and blood sugar, which can make lifestyle changes easier to sustain. Working with a healthcare professional or dietitian can help tailor these habits for long-term success. Why lifestyle still matters NICE and NHS guidance emphasise that Mounjaro should always be used alongside lifestyle modification. The medicine he

Yes — several large clinical trials, including the SURPASS and SURMOUNT studies, have shown that Mounjaro significantly lowers blood sugar and supports weight loss in adults with or without type 2 diabetes. In some trials, participants lost over 20 % of their body weight, depending on dose and duration. These results were published in respected medical journals and reviewed by agencies such as the MHRA and NICE. The major trials behind Mounjaro The key research programmes tha

Mounjaro targets two key hormone receptors in the body — GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). These hormones help regulate blood sugar, appetite, and energy use. By acting on both, Mounjaro improves how your body handles glucose while also curbing hunger, helping support steady, sustainable weight loss. How the GIP and GLP-1 hormones work Both GIP and GLP-1 are naturally released from the gut after eating. They signal the pan

Explore how Mounjaro (Tirzepatide) aids in type 2 diabetes and weight loss. Learn about approval, mechanism, dosage, and patient benefits.